An immunoassay to measure the concentration of Type 1 Collagen C-telopeptide breakdown products (β-CTx) in serum or plasma. This marker is considered a precise and early biochemical biomarker for the activity of osteoclasts and the rate of bone resorption. It is primarily used to assess fracture risk and monitor the response to anti-resorptive therapy.